The following research analysts cover Destiny Pharma.
|Dr Brian White, Cantor Fitzgerald Europe||+44(0)131 257 4621|
|Mark Brewer, finnCap||+44(0)20 7220 0500|
|Andy Smith, Edison Research||+44(0)20 3077 5700|
|Emma Ulker, Equity Development||+44(0)20 7065 2690|
|9th Jan 2018||Emma Ulker
|Initiation of coverage|
|19th Mar 2018||Emma Ulker
|Update: XF-73 green light for the fast track|
Equity Development’s web page concerning Destiny Pharma can be found here.
Some of this research is published on Research Tree